Avenue Therapeutics
ATXI • NASDAQ
Avenue Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Alexandra MacLean, with a market cap of $2.3M.
CEOAlexandra MacLean
Next Earnings
Upcoming earnings announcement for Avenue Therapeutics
Date
Thursday, May 14, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
Earnings History
Past 11 earnings reports for Avenue Therapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2025 | Q3 2025 | -$0.21 | — | - | — |  10-Q |
| Aug 14, 2025 | Q2 2025 | $0.11 | — | $1.4M | — | 10-Q |
| May 15, 2025 | Q1 2025 | -$0.62 | — | - | — | 10-Q |
| Mar 31, 2025 | Q4 2024 | $1.48 | — | - | — | 10-K |
| Nov 14, 2024 | Q3 2024 | -$1.92Est: -$0.94 | -104.3% | - | — | 10-Q |
| Aug 9, 2024 | Q2 2024 | -$6.43Est: -$1.05 | -512.4% | - | — | 10-Q |
| May 15, 2024 | Q1 2024 | -$15.40Est: -$9.00 | -71.1% | - | — | 10-Q |
| Mar 18, 2024 | Q4 2023 | $2.25Est: -$7.50 | +130.0% | - | — | 10-K |
| Nov 13, 2023 | Q3 2023 | $4.50Est: -$19.50 | +123.1% | - | — | — |
| Aug 10, 2023 | Q2 2023 | -$39.00Est: -$21.75 | -79.3% | - | — | 10-Q |
| May 12, 2023 | Q1 2023 | -$102.75 | — | - | — | — |